ROSWELL, Ga.--(BUSINESS WIRE)--Myelotec, Inc. a manufacturer of minimally invasive spinal and orthopedic medical devices including its line of steerable catheter and endoscope technologies, received notification on June 15th, 2012 that it has been awarded a Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs. These 5-year contracts are available for use by all US Government agencies.
“We are extremely pleased to have Myelotec added to the Federal Supply Schedule. TAMM Net, Inc. represents Myelotec to the VA and DoD and successfully negotiated this contract for us. The successful product validation process now positions Myelotec instruments for access and use by doctors at all Federal medical facilities,” said Richard Wunderlich, CEO of Myelotec. “In addition, Myelotec is in the process of initiating clinical trials in several of these locations, further cementing our relationship with federal medical treatment facilities.”
Combined, federal purchasers bought over $14 billion in healthcare products in 2011, the most recent year those figures are available. That number is in addition to over $3 billion purchased by the Department of Defense, who also awarded Myelotec a distribution and pricing agreement, DAPA. As a multiple contract holder, Myelotec will be able to add new products to these agreements as we expand our product line, creating significant value for the organization as a contract holder. This also makes it easier for Myelotec to work with distributors across the US.
About Myelotec: It designs and patents surgical products using a steerable catheter and endoscope as its core technology. Myelotec video guided catheters are cleared by the FDA for use in the lumbar and sacral spine for observing epidural anatomy, pathology, and delivery of drugs approved for epidural indications. With worldwide distribution agreements in place, its 12,000 square foot ISO 13485 facility manufacturers and assembles its patented FDA and CE Mark products in the United States at their Roswell, GA international headquarters.
About TAMM Net, Inc.: TAMM is a consultancy that provides services to biomedical manufacturers seeking opportunities or overcoming obstacles presented by the US government. TAMM provides full federal contracting services, regulatory affairs, reimbursement, and sales to federal medical facilities. More information is available at: www.tammnet.com.
Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company’s products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.